Skip to content

Colin Davidson

3 papers in the library · 175 citations · publishing 2012-2018

Papers

Sort Most recent Most cited

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter-In Silico and In Vitro Exploration of Dissociative Diarylethylamines.

Brain Sciences April 7, 2018 Michelle A Sahai, Colin Davidson, Neelakshi Dutta et al.

Novel psychoactive substances (NPS) may have unsuspected addiction potential through possessing stimulant properties. Stimulants normally act at the dopamine transporter (DAT) and thus increase dopamine (DA) availability in the brain, including nucleus accumbens, within the reward and addiction pathway. This paper aims to assess DAT responses to dissociative diarylethylamine NPS by means of in...

Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell

Journal of Psychopharmacology October 17, 2012 Daniel I. Brierley, Colin Davidson 42 citations

Harmine is a β-carboline alkaloid and major component of ayahuasca, a traditional South American psychoactive tea with anecdotal efficacy for treatment of cocaine dependence. Harmine is an inhibitor of monoamine oxidase A (MAO-A) and interacts in vitro with several pharmacological targets which modulate dopamine (DA) neurotransmission. In vivo studies have demonstrated dopaminergic effects of...

Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment

Progress in Neuro-psychopharmacology and Biological Psychiatry June 10, 2012 Daniel I. Brierley, Colin Davidson 133 citations

Ayahuasca is a hallucinogenic botanical mixture originating in the Amazon area where it is used ritually, but is now being taken globally. The 2 main constituents of ayahuasca are N,N-dimethyltryptamine (DMT), a hallucinogen, and harmine, a monoamine oxidase inhibitor (MAOI) which attenuates the breakdown of DMT, which would otherwise be broken down very quickly after oral consumption. Recent...